Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Puretech Health Plc (PRTC.LN)

Puretech Health Plc (PRTC.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Puretech Health Plc 6 Tide Street Suite 400 Boston MA 02210 USA

https://www.puretechhealth.com P: 617-482-2333 F: 617-482-3337

Description:

PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Internal, Controlled Founded Entities, Non-Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.

Key Statistics

Overview:

Market Capitalization, $K 578,683
Shares Outstanding, K 269,950
Annual Sales, $ 750 K
Annual Net Income, $ -65,697 K
% of Insider Shareholders 11.70%
% of Institutional Shareholders 52.42%

Growth:

1-Year Return -2.73%
3-Year Return -44.56%
5-Year Return 7.00%
5-Year Revenue Growth -46.02%

Per-Share Information:

Latest Earnings Date N/A
Earnings Per Share ttm -0.17
Dividend Payout Ratio 0.00%

PRTC.LN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Return-on-Equity % -13.06%
Return-on-Assets % -9.41%
Profit Margin % -8,759.60%
Debt/Equity 0.04
Price/Sales 984.63
Price/Book 1.56
Book Value/Share 1.37
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar